A detailed history of Dempze Nancy E transactions in Eli Lilly & CO stock. As of the latest transaction made, Dempze Nancy E holds 2,761 shares of LLY stock, worth $2.24 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
2,761
Previous 2,374 16.3%
Holding current value
$2.24 Million
Previous $1.96 Million 9.8%
% of portfolio
1.36%
Previous 1.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 23, 2025

BUY
$713.71 - $898.95 $276,205 - $347,893
387 Added 16.3%
2,761 $2.15 Million
Q1 2025

May 06, 2025

BUY
$725.72 - $929.72 $177,075 - $226,851
244 Added 11.46%
2,374 $1.96 Million
Q4 2024

Feb 12, 2025

SELL
$727.2 - $932.06 $374,508 - $480,010
-515 Reduced 19.47%
2,130 $1.64 Million
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $2.04 Million - $2.54 Million
2,645 New
2,645 $2.34 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $772B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Dempze Nancy E Portfolio

Follow Dempze Nancy E and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

News

Stay updated on Dempze Nancy E with notifications on news.